MARKET

PLSE

PLSE

Pulse Biosciences Inc
NASDAQ
53.11
-1.32
-2.43%
After Hours: 52.11 -1 -1.88% 19:30 09/11 EDT
OPEN
54.50
PREV CLOSE
54.43
HIGH
56.61
LOW
50.32
VOLUME
664.33K
TURNOVER
--
52 WEEK HIGH
58.90
52 WEEK LOW
12.56
MARKET CAP
3.79B
P/E (TTM)
-45.2192
1D
5D
1M
3M
1Y
5Y
1D
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
Benzinga · 2d ago
Why Pulse Biosciences Stock Popped Today
NASDAQ · 2d ago
Clinical Catalysts Drive Biotech Movers: Opus Genetics, Quantum & More
NASDAQ · 3d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 3d ago
Pulse Biosciences rises 19.5%
TipRanks · 3d ago
Pulse Biosciences Price Target Announced at $73.00/Share by Freedom Capital Markets
Dow Jones · 3d ago
Freedom Capital Markets Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $73
Benzinga · 3d ago
Analysts Are Bullish on These Healthcare Stocks: Agilent (A), AbSci (ABSI)
TipRanks · 3d ago
More
About PLSE
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s CellFX Nanosecond Pulsed-Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. It is pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation (AF) and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation. Its nsPFA Percutaneous Electrode System consists of a disposable, percutaneous, needle electrode for use with its CellFX Console. Its surgical cardiac ablation clamp is designed for use by cardiac surgeons during the surgical treatment of AF. The CellFX Console is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. It is also developing a Nanosecond PFA 360-degree Cardiac Catheter System.

Webull offers Pulse Biosciences Inc stock information, including NASDAQ: PLSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLSE stock methods without spending real money on the virtual paper trading platform.